Free Trial

Barclays Issues Positive Forecast for Intuitive Surgical (NASDAQ:ISRG) Stock Price

Intuitive Surgical logo with Medical background

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) had its price objective hoisted by research analysts at Barclays from $610.00 to $674.00 in a report released on Monday. Barclays's target price suggests a potential upside of 17.53% from the company's current price.

A number of other equities research analysts also recently weighed in on ISRG. Citigroup boosted their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a research note on Friday. The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a research report on Friday, October 18th. Stifel Nicolaus raised their price target on Intuitive Surgical from $525.00 to $610.00 and gave the stock a "buy" rating in a research report on Thursday, December 5th. Robert W. Baird upped their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the company an "outperform" rating in a report on Thursday, October 17th. Finally, Piper Sandler restated an "overweight" rating and set a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average target price of $613.10.

Read Our Latest Research Report on ISRG

Intuitive Surgical Stock Performance

NASDAQ:ISRG traded down $10.57 on Monday, hitting $573.48. 2,439,723 shares of the stock were exchanged, compared to its average volume of 2,025,429. Intuitive Surgical has a 52 week low of $364.17 and a 52 week high of $616.00. The stock has a market capitalization of $204.26 billion, a price-to-earnings ratio of 92.20, a P/E/G ratio of 5.19 and a beta of 1.39. The company's 50-day moving average price is $547.16 and its 200 day moving average price is $505.21.

Insider Transactions at Intuitive Surgical

In related news, insider Jamie Samath sold 269 shares of the stock in a transaction on Monday, November 11th. The shares were sold at an average price of $539.89, for a total transaction of $145,230.41. Following the completion of the transaction, the insider now owns 8,757 shares in the company, valued at approximately $4,727,816.73. This represents a 2.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the completion of the sale, the executive vice president now owns 5,506 shares in the company, valued at $2,788,899.12. The trade was a 3.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 42,453 shares of company stock valued at $22,059,506 over the last three months. Company insiders own 0.90% of the company's stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Massachusetts Financial Services Co. MA bought a new position in shares of Intuitive Surgical in the third quarter valued at $558,807,000. International Assets Investment Management LLC lifted its stake in Intuitive Surgical by 49,383.6% in the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider's stock valued at $535,788,000 after acquiring an additional 1,088,415 shares during the last quarter. FMR LLC grew its position in shares of Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock valued at $5,389,765,000 after acquiring an additional 838,793 shares during the period. Wilmington Savings Fund Society FSB increased its stake in shares of Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider's stock worth $272,980,000 after purchasing an additional 552,058 shares during the last quarter. Finally, State Street Corp raised its holdings in shares of Intuitive Surgical by 1.4% in the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider's stock valued at $7,393,673,000 after purchasing an additional 210,363 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

(Get Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Read More

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Should You Invest $1,000 in Intuitive Surgical Right Now?

Before you consider Intuitive Surgical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.

While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

NVIDIA Stock Under Pressure: DeepSeek and the AI Tech War

NVIDIA Stock Under Pressure: DeepSeek and the AI Tech War

NVIDIA's stock took a historic plunge, falling 17% on news of China's DeepSeek AI model; is now the time to buy the dip or wait for more volatility ahead?

Related Videos

Pelosi Bets Big on AI: Her Top 5 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025
7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines